News for Healthier Living

Assessment of HER2 Status in Extramammary Paget Disease and Its Implication for Disitamab Vedotin, a Novel Humanized Anti-HER2 Antibody-Drug Conjugate Therapy

Researchers from National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking University Cancer Hospital & Institute, et al. have conducted a paper entitled "Assessment of HER2 status in extramammary Paget disease and its implication for disitamab vedotin, a novel humanized anti-HER2 antibody-drug conjugate therapy". This study was published in Frontiers of Medicine, Volume 18, Issue 3.

November 7, 2025


November 21 2025

November 20 2025

November 19 2025

November 18 2025

November 17 2025

November 16 2025

November 15 2025

November 14 2025

November 13 2025

November 12 2025

November 11 2025

November 10 2025

November 9 2025

November 8 2025

November 7 2025